S Biomedics Co Ltd

XKRX:304360 (Korea (the Republic of))  
â‚© 17050.00 (-4.27%) Dec 24
At Loss
P/B:
19.16
Market Cap:
â‚© 209.19B ($ 137.41M)
Enterprise V:
â‚© 206.75B ($ 135.60M)
Volume:
89.62K
Avg Vol (2M):
394.85K
Trade In:
Volume:
89.62K
At Loss
Avg Vol (2M):
394.85K

Business Description

Description
S Biomedics Co Ltd researches and develops cell therapies for regenerative biomedicine. It owns two platform technologies: Functionally Enhanced Cell Spheroid and Targeted Embryonic Stem Cell Differentiation for developing cell therapy products that overcome the limitations of existing cell therapy products.
Name Current Vs Industry Vs History
Cash-To-Debt 1.21
Equity-to-Asset 0.3
Debt-to-Equity 1.09
Debt-to-EBITDA -3.16
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.05
Distress
Grey
Safe
Beneish M-Score -2.65
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 44.54
9-Day RSI 41.35
14-Day RSI 39.72
6-1 Month Momentum % -48.17
12-1 Month Momentum % 117.02

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.75
Quick Ratio 2.29
Cash Ratio 2
Days Inventory 157.32
Days Sales Outstanding 42.6
Days Payable 17.38

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.9
Shareholder Yield % -3.1
Name Current Vs Industry Vs History
Gross Margin % 51.01
Operating Margin % -44.72
Net Margin % -50.97
FCF Margin % -38.64
ROE % -99.23
ROA % -20.52
ROIC % -24.19
ROC (Joel Greenblatt) % -90.73
ROCE % -21.86

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 14.84
PB Ratio 19.16
Price-to-Tangible-Book 19.33
EV-to-EBIT -37.4
EV-to-EBITDA -54.79
EV-to-Revenue 15.19
EV-to-FCF -39.31
Earnings Yield (Greenblatt) % -2.67
FCF Yield % -2.51
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

S Biomedics Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil â‚©) 13,022.634
EPS (TTM) (â‚©) -573
Beta 0
Volatility % 206.08
14-Day RSI 39.72
14-Day ATR (â‚©) 1768.626568
20-Day SMA (â‚©) 18134.5
12-1 Month Momentum % 117.02
52-Week Range (â‚©) 7800 - 51600
Shares Outstanding (Mil) 11.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

S Biomedics Co Ltd Filings

Filing Date Document Date Form
No Filing Data

S Biomedics Co Ltd Stock Events

Financials Calendars
Event Date Price(â‚©)
No Event Data

S Biomedics Co Ltd Frequently Asked Questions

What is S Biomedics Co Ltd(XKRX:304360)'s stock price today?
The current price of XKRX:304360 is â‚©17050.00. The 52 week high of XKRX:304360 is â‚©51600.00 and 52 week low is â‚©7800.00.
When is next earnings date of S Biomedics Co Ltd(XKRX:304360)?
The next earnings date of S Biomedics Co Ltd(XKRX:304360) is .
Does S Biomedics Co Ltd(XKRX:304360) pay dividends? If so, how much?
S Biomedics Co Ltd(XKRX:304360) does not pay dividend.

Press Release

Subject Date
No Press Release